BENECCHI CHRISTOPHER (Chief Commercial Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/21/2025ACC: 0001562180-25-000435
Officer· Chief Commercial Officer
Since Sep 2021
+60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
80.9%
1/16/2025
24.74K→44.74K
Total
Net shares
+20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2025 | A · Award | +20K | — | — | 80.9% | 24.74K | 44.74K |
| Total | +20K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
40K shares
Shares
+40K
Strike price
6.97
Held after
40K
Exercisable
—
1/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock40K shares | 1/16/2025 | A · Award | +40K | 6.97 | — | 40K |